[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:claudin-18-isoform-a2":3},{"name":4,"total":5,"recruiting":6,"trials":7},"Claudin-18 Isoform A2",11,10,[8,16,23,29,35,40,47,53,60,66,72],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06901531","A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer",[12],"Phase 3","RECRUITING","2026-08-26T02:18:33.598205Z","2026-07-05T05:32:16.705484Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07024615","A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer",[20],"Phase 1","2026-08-26T02:15:26.669629Z","2026-05-05T02:43:27.401522Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT05365581","A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer",[20],"2026-08-26T02:17:42.501124Z","2026-07-05T05:32:16.805238Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT07431281","Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2",[12],"2026-08-26T02:16:04.914942Z","2026-05-05T02:43:29.651140Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":27,"content_modified":39},"NCT05458219","A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors",[20],"2026-05-05T02:43:29.294686Z",{"nct_id":41,"title":42,"phases":43,"status":13,"updated_at":45,"content_modified":46},"NCT07432295","Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)",[44],"Phase 2","2026-08-26T02:15:45.413021Z","2026-05-05T02:43:29.196980Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07069712","A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma",[44],"2026-08-26T02:19:12.219640Z","2026-05-05T02:43:28.835650Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT06005493","Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors",[57],"Phase 1\u002FPhase 2","2026-08-26T02:17:01.714035Z","2026-05-05T02:43:28.867321Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06219941","AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2",[44],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:27.246686Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07546812","Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas",[44],"2026-08-26T02:16:10.529598Z","2026-07-19T19:36:05.144248Z",{"nct_id":73,"title":74,"phases":75,"status":76,"updated_at":77,"content_modified":78},"NCT06921928","Study for AZD4360 in Participants With Advanced Solid Tumours",[57],"ACTIVE_NOT_RECRUITING","2026-08-03T03:01:15.394071Z","2026-04-29T02:57:57.154395Z"]